Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 1, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001752439-26-000002
Filed / recorded
Mar 4, 2026, 12:16 AM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Elanco Animal Health Inc
Issuer CIK
1739104
Ticker
ELAN
Reporting person
David S Kinard
Relationship
Officer
Officer title
SEE REMARKS
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 1, 2026
Transaction code
A
Shares / units
33,087
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
223,604
Ownership form
Direct
Amendment
No
Footnotes from the filing
Includes 648 shares acquired on April 30, 2025, 518 shares acquired on July 31, 2025, 221 shares acquired on October 31, 2025, and 252 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .